MXCT
MaxCyte, Inc. · Healthcare
Director Stanley C Erck sold $179K of MaxCyte, Inc.
Sold$178,752
$3.75Price
47,689Shares
−15%Stake
What MXCT did after the filing
- The stock from Wed, Oct 2 close, $3.74
- −5.1%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Nov 13 close.
Traded Tue, Oct 1. Filed Wed, Oct 2, 1:03 PM ET, during the session. Returns use the Oct 2 close and the Nov 13 close. Not investment advice.